Chasman, D. I., Shiffman, D., Zee, R. Y., Louie, J. Z., Luke, M. M., Rowland, C. M., . . . Ridker, P. M. (2009). Polymorphism in the apolipoprotein(a) gene, plasma lipoprotein(a), cardiovascular disease, and low-dose aspirin therapy. Atherosclerosis, 203(2), 371-376. https://doi.org/10.1016/j.atherosclerosis.2008.07.019
Chicago-Zitierstil (17. Ausg.)Chasman, Daniel I., et al. "Polymorphism in the Apolipoprotein(a) Gene, Plasma Lipoprotein(a), Cardiovascular Disease, and Low-dose Aspirin Therapy." Atherosclerosis 203, no. 2 (2009): 371-376. https://doi.org/10.1016/j.atherosclerosis.2008.07.019.
MLA-Zitierstil (9. Ausg.)Chasman, Daniel I., et al. "Polymorphism in the Apolipoprotein(a) Gene, Plasma Lipoprotein(a), Cardiovascular Disease, and Low-dose Aspirin Therapy." Atherosclerosis, vol. 203, no. 2, 2009, pp. 371-376, https://doi.org/10.1016/j.atherosclerosis.2008.07.019.